Literature DB >> 32371902

Gastric bypass bariatric surgery in patients undergoing allogeneic hematopoietic stem cell transplantation warrants special considerations.

Usama Gergis1, Ronit Reich-Slotky2, Brenda Abdulahad3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32371902     DOI： 10.1038/s41409-020-0922-5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

Review 1.  Nutritional and metabolic support in patients undergoing bone marrow transplantation.

Authors:  Maurizio Muscaritoli; Gabriella Grieco; Saveria Capria; Anna Paola Iori; Filippo Rossi Fanelli
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

2.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

Authors:  Mukta Arora; John P Klein; Daniel J Weisdorf; Anna Hassebroek; Mary E D Flowers; Corey S Cutler; Alvaro Urbano-Ispizua; Joseph H Antin; Brian J Bolwell; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Luis Isola; David A Jacobsohn; Madan Jagasia; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Robert Peter Gale; Harry C Schouten; Stephen Spellman; John R Wingard; Mary M Horowitz; Steven Z Pavletic
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

3.  Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study.

Authors:  D R Fleming; M K Rayens; J Garrison
Journal:  Am J Med       Date:  1997-03       Impact factor: 4.965

4.  Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies.

Authors:  Emmanouil Nikolousis; Sandeep Nagra; Shankara Paneesha; Julio Delgado; Kathy Holder; Lynn Bratby; Sridhar Chaganti; Richard Lovell; Donald Milligan
Journal:  Ann Hematol       Date:  2010-06-11       Impact factor: 3.673

5.  Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

Authors:  Willis H Navarro; Manza-A Agovi; Brent R Logan; Karen Ballen; Brian J Bolwell; Haydar Frangoul; Vikas Gupta; Theresa Hahn; Vincent T Ho; Mark Juckett; Hillard M Lazarus; Mark R Litzow; Jane L Liesveld; Jan S Moreb; David I Marks; Philip L McCarthy; Marcelo C Pasquini; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-20       Impact factor: 5.742

6.  Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Authors:  Jean-Pierre Furet; Ling-Chun Kong; Julien Tap; Christine Poitou; Arnaud Basdevant; Jean-Luc Bouillot; Denis Mariat; Gérard Corthier; Joël Doré; Corneliu Henegar; Salwa Rizkalla; Karine Clément
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

7.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

Authors:  Christin C Rogers; Rita R Alloway; J Wesley Alexander; Michael Cardi; Jennifer Trofe; Alexander A Vinks
Journal:  Clin Transplant       Date:  2008 May-Jun       Impact factor: 2.863

Review 8.  Trimming the fat: obesity and hematopoietic cell transplantation.

Authors:  B M Weiss; D T Vogl; N A Berger; E A Stadtmauer; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2012-10-29       Impact factor: 5.483

Review 9.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.